Trillium Therapeutics Inc (TRIL.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,887 | 4,303 | 5,259 | 10,870 | 890 |
| Marketable Securities | N/A | N/A | N/A | N/A | 52 |
| Receivables | 20 | 105 | 48 | 141 | 18 |
| Other current assets | 20 | 80 | 68 | 82 | 0 |
| TOTAL | $2,972 | $4,525 | $5,594 | $11,492 | $1,104 |
| Non-Current Assets | |||||
| PPE Net | 4 | 14 | 34 | 59 | 52 |
| Intangibles | 927 | 1,104 | 1,150 | 1,659 | 1,618 |
| Other Non-Current Assets | 0 | 0 | 0 | 3 | 3 |
| TOTAL | $932 | $1,118 | $1,184 | $1,721 | $1,673 |
| Total Assets | $3,904 | $5,643 | $6,778 | $13,213 | $2,778 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 1,507 | 387 |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 757 | 366 |
| TOTAL | $336 | $609 | $825 | $2,264 | $753 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 1,231 |
| TOTAL | $0 | $0 | $3 | $10 | $1,233 |
| Total Liabilities | $336 | $609 | $828 | $2,274 | $1,986 |
| Shareholders' Equity | |||||
| Retained earnings | -29,105 | -23,541 | -16,428 | -14,575 | -7,704 |
| TOTAL | $3,568 | $5,035 | $5,950 | $10,939 | $792 |
| Total Liabilities And Equity | $3,904 | $5,643 | $6,778 | $13,213 | $2,778 |